Perceptive Advisors

Portfolio Companies 2026 for Perceptive Advisors: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.

Perceptive Advisors accounts for 47 tracked companies with verified cap-table data, 47 of which disclose round sizes totalling $12B. The median disclosed raise is $172M, and the largest is InSightec at $800M, ahead of LianBio ($719M) and Astria Therapeutics ($700M).

The names that recur most often on these portfolio cap tables are Perceptive Advisors (47 companies), RA Capital Management (12 companies), Ally Bridge Group (6 companies), Surveyor Capital (6 companies), Casdin Capital (6 companies), Logos Capital (5 companies). By latest disclosed round, the market skews Series B (9), Series C (9), Series A (8), Growth (5).

Best funded Perceptive Advisors companies

  1. InSightec — $800M (latest: Growth)
  2. LianBio — $719M (latest: Growth)
  3. Astria Therapeutics — $700M (latest: Growth)
  4. Point Biopharma — $650M (latest: IPO)
  5. Spyre Therapeutics — $644M (latest: Growth)
  6. Imperative Care — $595M (latest: Other Equity)
  7. DNAnexus — $473M (latest: Series H)
  8. Synthego — $460M (latest: Series E)
  9. Cerevel Therapeutics — $445M (latest: IPO)
  10. Nautilus Biotechnology — $445M (latest: IPO)
  11. Impulse Dynamics — $443M (latest: Series E)
  12. Forge Biologics — $330M (latest: Series B)
  13. Pyxis Oncology — $326M (latest: IPO)
  14. Kardigan — $300M (latest: Series B)
  15. Endeavor BioMedicines — $292M (latest: Series A)

Perceptive Advisors — related firms and companies (50)

Perceptive Advisors profile · All research reports